These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17396622)

  • 1. Anti-retroviral activity of GMP-grade stampidine against genotypically and phenotypically nucleoside reverse transcriptase inhibitor resistant recombinant human immunodeficiency virus. An in vitro study.
    Uckun FM; DuMez D; Qazi S; Tibbles H; Venkatachalam TK
    Arzneimittelforschung; 2007; 57(2):112-21. PubMed ID: 17396622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency of stampidine against multi-nucleoside reverse transcriptase inhibitor resistant human immunodeficiency viruses.
    Uckun FM; Venkatachalam TK; Qazi S
    Arzneimittelforschung; 2006 Feb; 56(2A):193-203. PubMed ID: 16570827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates.
    Uckun FM; Pendergrass S; Qazi S; Venkatachalam TK
    Arzneimittelforschung; 2004; 54(1):69-77. PubMed ID: 14979612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activity.
    Uckun FM
    Arzneimittelforschung; 2006 Feb; 56(2A):121-35. PubMed ID: 16570821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.
    Uckun FM; Pendergrass S; Venkatachalam TK; Qazi S; Richman D
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3613-6. PubMed ID: 12384373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
    Uckun FM; Qazi S; Venkatachalam TK
    Arzneimittelforschung; 2005; 55(4):223-31. PubMed ID: 15901046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS.
    Uckun FM; Cahn P; Qazi S; D'Cruz O
    Expert Opin Investig Drugs; 2012 Apr; 21(4):489-500. PubMed ID: 22360744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a thermoreversible ovule formulation of stampidine, a novel nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Samuel P; Waurzyniak B; Uckun FM
    Biol Reprod; 2003 Dec; 69(6):1843-51. PubMed ID: 12890726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmet challenges in HIV therapy and potential of stampidine.
    Uckun FM
    Arzneimittelforschung; 2006 Feb; 56(2A):117-20. PubMed ID: 16570820
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice.
    Uckun FM; Qazi S; Pendergrass S; Lisowski E; Waurzyniak B; Chen CL; Venkatachalam TK
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3428-36. PubMed ID: 12384347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, separation and anti-HIV activity of distereoisomers of N-[p-(4-bromophenyl) -2',3'-didehydro-3'-deoxy-5'-thymidylyl]-L-alanine methyl ester (stampidine).
    Venkatachalam TK; Qazi S; Uckun FM
    Arzneimittelforschung; 2006 Feb; 56(2A):152-8. PubMed ID: 16570823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stampidine is a potential nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Fertil Steril; 2004 Mar; 81 Suppl 1():831-41. PubMed ID: 15019817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbicides for multidrug-resistant and multitropic HIV-1.
    D'Cruz OJ; Uckun FM
    Curr Opin Investig Drugs; 2008 Feb; 9(2):152-69. PubMed ID: 18246518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
    Miller V; Larder BA
    Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereochemical influence on lipase-mediated hydrolysis and biological activity of stampidine and other stavudine phosphoramidates.
    Venkatachalam TK; Samuel P; Uckun FM
    Bioorg Med Chem; 2005 Mar; 13(5):1763-73. PubMed ID: 15698793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stampidine: a selective oculo-genital microbicide.
    D'Cruz OJ; Uckun FM
    J Antimicrob Chemother; 2005 Jul; 56(1):10-9. PubMed ID: 15919769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.
    Paolucci S; Baldanti F; Campanini G; Cancio R; Belfiore A; Maga G; Gerna G
    Antiviral Res; 2007 Nov; 76(2):99-103. PubMed ID: 17640745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure.
    Marcelin AG; Delaugerre C; Wirden M; Viegas P; Simon A; Katlama C; Calvez V
    J Med Virol; 2004 Jan; 72(1):162-5. PubMed ID: 14635026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on the selective kinetics of HIV-1 nucleoside reverse transcriptase inhibitor drug resistance-associated mutations among 4 AIDS patients receiving highly active antiretroviral therapy].
    Li J; Jiao LY; Li HP; Li L; Liu YJ; Zhuang DM; Liu SY; Bao ZY; Li H; Wang Z; Li JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):794-800. PubMed ID: 19103117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.
    Zhang Z; Walker M; Xu W; Shim JH; Girardet JL; Hamatake RK; Hong Z
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2772-81. PubMed ID: 16870771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.